These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33779087)

  • 41. Very late-onset amyotrophic lateral sclerosis in a Portuguese cohort.
    Santos MO; Gromicho M; Pinto S; de Carvalho M
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):619-622. PubMed ID: 30265147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical polymorphism of amyotrophic lateral sclerosis].
    Kovrazhkina EA; Razinskaya OD; Gubsky LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(8):4-10. PubMed ID: 28884711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A retrospective study of the clinical phenotype and predictors of survival in non-Caucasian Hispanic patients with amyotrophic lateral sclerosis.
    Sánchez-Martínez CM; Choreño-Parra JA; Nuñez-Orozco L; Placencia-Álvarez N; Alvis-Castaño LM; Guadarrama-Ortiz P
    BMC Neurol; 2019 Oct; 19(1):261. PubMed ID: 31664949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical characteristics of elderly Japanese patients with amyotrophic lateral sclerosis; with special reference to the development of respiratory failure].
    Terao S; Miura N; Osano Y; Adachi K; Sobue G
    Rinsho Shinkeigaku; 2006 Jun; 46(6):381-9. PubMed ID: 16986698
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical characteristics of amyotrophic lateral sclerosis subsets].
    Pradat PF; Bruneteau G
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S29-4S33. PubMed ID: 17128087
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patterns of grey and white matter changes differ between bulbar and limb onset amyotrophic lateral sclerosis.
    Steinbach R; Prell T; Gaur N; Roediger A; Gaser C; Mayer TE; Witte OW; Grosskreutz J
    Neuroimage Clin; 2021; 30():102674. PubMed ID: 33901988
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort.
    Talman P; Duong T; Vucic S; Mathers S; Venkatesh S; Henderson R; Rowe D; Schultz D; Edis R; Needham M; Macdonnell R; McCombe P; Birks C; Kiernan M
    BMJ Open; 2016 Sep; 6(9):e012054. PubMed ID: 27694488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.
    Westeneng HJ; Debray TPA; Visser AE; van Eijk RPA; Rooney JPK; Calvo A; Martin S; McDermott CJ; Thompson AG; Pinto S; Kobeleva X; Rosenbohm A; Stubendorff B; Sommer H; Middelkoop BM; Dekker AM; van Vugt JJFA; van Rheenen W; Vajda A; Heverin M; Kazoka M; Hollinger H; Gromicho M; Körner S; Ringer TM; Rödiger A; Gunkel A; Shaw CE; Bredenoord AL; van Es MA; Corcia P; Couratier P; Weber M; Grosskreutz J; Ludolph AC; Petri S; de Carvalho M; Van Damme P; Talbot K; Turner MR; Shaw PJ; Al-Chalabi A; Chiò A; Hardiman O; Moons KGM; Veldink JH; van den Berg LH
    Lancet Neurol; 2018 May; 17(5):423-433. PubMed ID: 29598923
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The prognostic value of spirometric tests in Amyotrophic Lateral Sclerosis patients.
    Pirola A; De Mattia E; Lizio A; Sannicolò G; Carraro E; Rao F; Sansone V; Lunetta C
    Clin Neurol Neurosurg; 2019 Sep; 184():105456. PubMed ID: 31382080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The path to specialist multidisciplinary care in amyotrophic lateral sclerosis: A population- based study of consultations, interventions and costs.
    Galvin M; Ryan P; Maguire S; Heverin M; Madden C; Vajda A; Normand C; Hardiman O
    PLoS One; 2017; 12(6):e0179796. PubMed ID: 28640860
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of Patients with Amyotrophic Lateral Sclerosis attending the Muscular Dystrophy Association-Supported Clinics in Puerto Rico.
    Deliz B; Ramos K; Pérez CM
    P R Health Sci J; 2018 Mar; 37(1):5-11. PubMed ID: 29547678
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early symptom progression rate is related to ALS outcome: a prospective population-based study.
    Chiò A; Mora G; Leone M; Mazzini L; Cocito D; Giordana MT; Bottacchi E; Mutani R;
    Neurology; 2002 Jul; 59(1):99-103. PubMed ID: 12105314
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Demographics, clinical characteristics, and prognostic factors of amyotrophic lateral sclerosis in Midwest.
    Yamakawa M; Dwyer S; Song X; Statland J
    Muscle Nerve; 2022 Feb; 65(2):217-224. PubMed ID: 34708421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study.
    Traynor BJ; Codd MB; Corr B; Forde C; Frost E; Hardiman OM
    Arch Neurol; 2000 Aug; 57(8):1171-6. PubMed ID: 10927797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Longitudinal analysis of progression of dysphagia in amyotrophic lateral sclerosis.
    Higo R; Tayama N; Nito T
    Auris Nasus Larynx; 2004 Sep; 31(3):247-54. PubMed ID: 15364359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Time from amyotrophic lateral sclerosis symptom onset to key disease milestones: analysis of data from a multinational cross-sectional survey.
    Gebrehiwet P; Brekke J; Rudnicki SA; Mellor J; Wright J; Earl L; Ball N; Iqbal H; Thomas O; Castellano G
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 May; 25(3-4):345-357. PubMed ID: 38156828
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amyotrophic Lateral Sclerosis Regional Variants (Brachial Amyotrophic Diplegia, Leg Amyotrophic Diplegia, and Isolated Bulbar Amyotrophic Lateral Sclerosis).
    Jawdat O; Statland JM; Barohn RJ; Katz JS; Dimachkie MM
    Neurol Clin; 2015 Nov; 33(4):775-85. PubMed ID: 26515621
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis.
    Mandrioli J; Ferri L; Fasano A; Zucchi E; Fini N; Moglia C; Lunetta C; Marinou K; Ticozzi N; Drago Ferrante G; Scialo C; Sorarù G; Trojsi F; Conte A; Falzone YM; Tortelli R; Russo M; Sansone VA; Mora G; Silani V; Volanti P; Caponnetto C; Querin G; Monsurrò MR; Sabatelli M; Chiò A; Riva N; Logroscino G; Messina S; Calvo A
    Eur J Neurol; 2018 Jun; 25(6):861-868. PubMed ID: 29512869
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Late age onset of amyotrophic lateral sclerosis is often not considered in elderly people.
    Broussalis E; Grinzinger S; Kunz AB; Killer-Oberpfalzer M; Haschke-Becher E; Hartung HP; Kraus J
    Acta Neurol Scand; 2018 Mar; 137(3):329-334. PubMed ID: 29148035
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions.
    Manera U; D'Ovidio F; Cabras S; Torrieri MC; Canosa A; Vasta R; Palumbo F; Grassano M; De Marchi F; Mazzini L; Mora G; Moglia C; Calvo A; Chiò A
    Eur J Neurol; 2023 Apr; 30(4):872-880. PubMed ID: 36617536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.